Dr John S Bolton, MD | |
1514 Jefferson Hwy, New Orleans, LA 70121-2429 | |
(504) 842-4000 | |
Not Available |
Full Name | Dr John S Bolton |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1514 Jefferson Hwy, New Orleans, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154389039 | NPI | - | NPPES |
1321877 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD.013758 (Louisiana) | Secondary |
2086X0206X | Surgery - Surgical Oncology | MD.013758 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John S Bolton, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Dr John S Bolton, MD 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 |
News Archive
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
A new study has found that men who regularly consume foods rich in flavonoids, such as berries, apples, certain vegetables, tea and red wine, may significantly reduce their risk for developing Parkinson's disease. The study was published in the journal Neurology this week. It added that there was no such effect among women.
A Rochester Institute of Technology researcher has validated a tool measuring adherence to a popular child feeding approach used by pediatricians, nutritionists, social workers and child psychologists to assess parents' feeding practices and prevent feeding problems.
Sanofi announced today that Lyxumia (lixisenatide), a once-daily GLP-1 receptor agonist under development for type 2 diabetes, achieved its primary efficacy endpoint of significant HbA1c reduction vs. placebo in patients uncontrolled on metformin.
Patients suffering from chronic obstructive pulmonary disease (COPD) are at a higher risk of death if they are underweight.
› Verified 7 days ago
Danielle M Pickham, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-3000 | |
Dr. Carlos Galvani, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave, New Orleans, LA 70112 Phone: 504-988-6855 | |
Amanda Tullos, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1430 Tulane Ave Rm 734, New Orleans, LA 70112 Phone: 501-920-4647 | |
David S Bruce, M. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Highway, New Orleans, LA 70121 Phone: 504-842-4000 | |
Dr. Robert M. Arensman, MD Surgery Medicare: Medicare Enrolled Practice Location: 1514 Jefferson Hwy, New Orleans, LA 70121 Phone: 504-842-4000 | |
Hernan Antonio Bazan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1514 Jefferson Highway, 8th Floor-clinic, New Orleans, LA 07012 Phone: 504-842-4053 Fax: 504-842-5017 | |
Kiara Tulla, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave # 8622, New Orleans, LA 70112 Phone: 504-988-2306 |